Side-by-side comparison of AI visibility scores, market position, and capabilities
NYC grocery operating system (VoriOS) for independent stores with integrated POS, supplier ordering, and pricing; $15.3M total ($10M Greylock/The Factory Series A Aug 2022) planning Series B 2025 competing with PDI Technologies for independent grocer technology.
Vori is a New York City-based grocery technology company — backed with $15.3 million in total funding including a $10 million Series A in August 2022 led by The Factory with Greylock — providing independent grocery stores with an all-in-one VoriOS cloud-based operating system launched in July 2024 after an 18-month closed beta, combining point-of-sale, supplier-integrated back office, automated pricing management, and shopper engagement tools designed specifically for independent grocers competing against national chains with sophisticated retail technology. Vori launched initially in California and the New York City metropolitan area and plans to raise a Series B as of March 2025 for geographic expansion.
Richmond VA tobacco and nicotine (NYSE: MO) ~$9.7B net revenue FY2024; Marlboro 40%+ US cigarette share, on! oral pouch competing with Zyn, 50%+ operating margins, ABI stake, competing with Reynolds/BAT.
Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and selling cigarettes (Marlboro — the best-selling cigarette brand in the United States), smokeless tobacco (Copenhagen, Skoal, Red Seal, Husky chewing tobacco/moist snuff brands), oral nicotine pouches (on! brand), and maintaining a 10.7% ownership stake in Anheuser-Busch InBev (SABMiller acquisition consideration shares) and a 35% stake in JUUL Labs (vaping — original $12.8B investment written down to minimal value following JUUL's regulatory and litigation difficulties) through approximately 5,500 employees. In fiscal year 2024, Altria reported revenues of approximately $20.6 billion (net revenues after excise taxes approximately $9.7 billion), with the cigarette segment (Marlboro generating 40%+ US cigarette market share) contributing the majority of operating income at 50%+ adjusted operating margins — the highest margins in the consumer staples sector reflecting cigarettes' inelastic demand and regulated market structure. CEO Billy Gifford has pivoted Altria's strategy from cigarettes toward smoke-free nicotine products: the on! oral nicotine pouch (acquired full ownership of Helix Innovations in 2023, rebranding as on! to compete with Swedish Match Zyn, the dominant US oral nicotine pouch brand) represents Altria's primary nicotine product diversification vehicle as cigarette volume declines 7-8% annually through consumer quit rates and secular health awareness trends.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.